BioPharmSignal logoBioPharmSignal

Biotech News

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

Lifevantage (LFVN)LifevantageEarnings

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026.

Related news

LFVNLifevantage2026-02-04 21:04 EST

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

LFVNLifevantage2026-04-22 20:05 EST

LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

View all latest news

Lifevantage

Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather...

Recent company news

LFVNLifevantage2026-05-06 20:06 EST

LifeVantage Declares Quarterly Dividend

LFVNLifevantage2026-05-06 20:05 EST

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

LFVNLifevantage2026-04-22 20:05 EST

LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

LFVNLifevantage2026-04-21 12:00 EST

LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

LFVNLifevantage2026-04-20 12:00 EST

LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas

Stock data

Close
6.58 USD
Market cap
108.75M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States